AstraZeneca to Acquire U.S. Biotech Firm CinCor for Up to $1.8 Billion
- January 13, 2023
AstraZeneca announced January 9 plans to acquire U.S.-based biopharmaceutical company CinCor Pharma, Inc. for up to $1.8 billion.
ARTICLE TAGS
You must be logged in to access this content.